...
首页> 外文期刊>Case Reports in Dermatological Medicine >A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma
【24h】

A Unique Presentation of Cutaneous Diffuse Large B-Cell Lymphoma

机译:皮肤弥漫性大B细胞淋巴瘤的独特呈现

获取原文
           

摘要

Cutaneous B-cell lymphomas (CBCL) are rare heterogeneous neoplastic diseases composing about 22.5% of all cutaneous lymphomas. These diseases can be divided into primary and secondary cutaneous variants with primary cutaneous B-cell lymphoma (PCBCL) divided into three distinct entities including primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL, LT). Secondary cutaneous diffuse large B-cell lymphoma (CDLBCL) and PCDLBCL, LT are more aggressive neoplasms compared to the aforementioned CBCL with survival rates of 37% and 50% after 5 years, respectively. CDLBCL can present as cutaneous or subcutaneous nodules, papular lesions, or indurated plaques. Here, we present a case of CDLBCL of an 88-year-old female that was mistaken for lower extremity cellulitis with phlegmon. Our patient failed two courses of antibiotic therapy as an outpatient and received a third as an inpatient before a cutaneous biopsy clinched the diagnosis.
机译:皮肤B细胞淋巴瘤(CBCL)是罕见的异质肿瘤疾病,作曲组成约22.5%的皮肤淋巴瘤。这些疾病可分为初级和次要皮肤变体,初级皮肤B细胞淋巴瘤(PCBCL)分为三个不同的实体,包括初级皮肤边缘区淋巴瘤,初级皮肤卵泡中心淋巴瘤和初级皮肤弥漫性大B细胞淋巴瘤,腿部类型(pcdlbcl,lt)。次要皮肤漫反射大B细胞淋巴瘤(CDLBCL)和PCDLBCL,与前述CBCL相比,与前述CBCL分别为37%和50%后的上述CBCL,分别为37%和50%。 CDLBCL可以作为皮肤或皮下结节,丘疹病变或诱导斑块呈现。在这里,我们提出了一个88岁女性CDLBCL的CDLBCL,据误认为是低端蜂窝织炎。我们的病人失败了两种抗生素治疗疗法,作为门诊,并在皮肤活检之前收到三分之一作为住院病患者诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号